Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma

Japanese Journal of Clinical Oncology
Masafumi IkedaAtsushi Hagihara

Abstract

Systemic chemotherapy is an important treatment modality for metastatic hepatocellular carcinoma (HCC); however, the predictive factors of outcome and tumor response have not been fully investigated. The aim of this study was to identify factors that could be used to predict outcome and tumor response to systemic chemotherapy in patients with metastatic HCC. We retrospectively examined 82 consecutive patients with metastatic HCC undergoing systemic chemotherapy to investigate factors associated with outcome and tumor response. The patients underwent 5-fluorouracil, mitoxantrone and cisplatin (FMP) therapy. The overall objective response rate was 22% (95% confidence interval, 14-32), and the median survival time and 1-year survival for all patients were 11.2 months and 43.5%, respectively. Multivariate analysis demonstrated that the absence of radiologically active intrahepatic disease (P = 0.02) and ascites (P = 0.002) was independent favorable prognostic factors. Although multivariate analysis revealed no significant predictive factors of tumor response, the response rates in patients without radiologically active intrahepatic disease (response rate, 46%) tended to be higher than those in patients with active intrahepatic dise...Continue Reading

References

Jul 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S OkadaK Aoki
Feb 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L Dexter, J T Leith
Aug 1, 1973·The British Journal of Surgery·R N PughR Williams
Dec 9, 1997·Japanese Journal of Clinical Oncology·H NagahamaM Yoshimori
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J M LlovetJ Bruix
Oct 31, 2001·Seminars in Oncology·A Aguayo, Y Z Patt
Jun 16, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anna K NowakMichael Findlay
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melanie B Thomas, Andrew X Zhu
Nov 4, 2005·Journal of Neurosurgery·Jun DeguchiToshihiko Kuroiwa
Jul 25, 2006·Critical Reviews in Oncology/hematology·Alejandro FornerJordi Bruix
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
May 9, 2008·Blood·Massimo Franchini, Giuseppe Lippi

❮ Previous
Next ❯

Citations

Aug 26, 2015·Journal of Experimental & Clinical Cancer Research : CR·Silvia UssaiFrancesca Pentimalli
Oct 5, 2017·Cancer Control : Journal of the Moffitt Cancer Center·Jennifer EatridesRichard Kim
Feb 1, 2008·Annals of Surgical Oncology·Melanie B ThomasPhilip Johnson
Oct 31, 2009·World Journal of Hepatology·Toru Ishikawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Related Papers

Journal of Gastroenterology and Hepatology
D Y LinY F Liaw
Journal of Cancer Research and Clinical Oncology
Kimberly B HigginbothamMelanie B Thomas
CA: a Cancer Journal for Clinicians
Rebecca SiegelAhmedin Jemal
Nature Reviews. Cancer
Michael DeanSusan Bates
© 2022 Meta ULC. All rights reserved